Nov 23,2020

Tandem Diabetes Care Announces Health Canada Approval of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada approval of the t:slim X2™ insulin pump with Control-IQ™ technology. Control-IQ technology is an advanced hybrid closed-loop feature designed to help increase time in range (3.9-10 mmol/L)1 and deliver automatic correction boluses in addition to adjusting insulin to help prevent high and low blood sugar.

REGULATORY FDA

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 01,2020

Diabeloop introduces an automated management solution for highly unstable diabetes

Diabeloop announced today that it has obtained CE marking for its innovative and adjustable technological solution: DBL-hu. DBL-hu improves glycemic control and satisfaction for people living with a form of diabetes that is very complex to manage. Diabeloop expands its position in therapeutic artificial intelligence, following CE marking of DBLG1 in 2018.

REGULATORY CE MARK
View Analyst & Ambassador Comments
Go to original news
Dec 18,2020

Actiste® Mini receives market approval in the Kingdom of Saudi Arabia

Brighter AB (publ) is proud to announce that the diabetes management device Actiste® Mini has received market approval from the Saudi Food and Drug Authority (SFDA).

REGULATORY FDA
View Analyst & Ambassador Comments
Go to original news
Subscribe to REGULATORY